The dash-dash broken lines illustrate portions of the article that form no part of the claimed design. The dot-dash broken lines define the bounds of the claimed design and form no part thereof.
The dash-dash broken lines illustrate portions of the article that form no part of the claimed design. The dot-dash broken lines define the bounds of the claimed design and form no part thereof.
Number | Name | Date | Kind |
---|---|---|---|
D512777 | Beisner | Dec 2005 | S |
D579544 | Birath | Oct 2008 | S |
D613397 | Nakao | Apr 2010 | S |
D637280 | Harvey | May 2011 | S |
D637281 | Harvey | May 2011 | S |
D645734 | Eason | Sep 2011 | S |
D657045 | Palmer-Felgate | Apr 2012 | S |
D683844 | Andrade | Jun 2013 | S |
D684254 | Zuyderhoudt | Jun 2013 | S |
8667961 | Thoemmes | Mar 2014 | B2 |
D739522 | Von Schuckmann | Sep 2015 | S |
D755950 | Meliniotis | May 2016 | S |
D791931 | Kang | Jul 2017 | S |
D831190 | Von Schuckmann | Oct 2018 | S |
D847973 | Haeger | May 2019 | S |
D849927 | Von Schuckmann | May 2019 | S |
D855792 | Toksoz | Aug 2019 | S |
D863529 | Clement | Oct 2019 | S |
D869636 | Castellucci | Dec 2019 | S |
D869638 | Shinichi | Dec 2019 | S |
D879943 | Ono | Mar 2020 | S |
D879944 | Ono | Mar 2020 | S |
D888931 | Li | Jun 2020 | S |
D948705 | Cotton | Apr 2022 | S |
D952129 | Lastow | May 2022 | S |
D960350 | Cotton | Aug 2022 | S |
20060137682 | Tseng | Jun 2006 | A1 |
20110186047 | Lewis | Aug 2011 | A1 |
20110192397 | Saskar | Aug 2011 | A1 |
20150096563 | Toksoz | Apr 2015 | A1 |
20160045684 | Ono | Feb 2016 | A1 |
20190328984 | Yang | Oct 2019 | A1 |
20190388632 | Krasnow | Dec 2019 | A1 |
20200078538 | Wang | Mar 2020 | A1 |
20200316322 | Wilson | Oct 2020 | A1 |
20210268214 | Clarke | Sep 2021 | A1 |
20220096762 | Von Schuckmann | Mar 2022 | A1 |
20220126035 | Von Schuckmann | Apr 2022 | A1 |
Entry |
---|
Merxin Ltd [@MRXdevices]. “Introductions aren't always necessary . . . Merxin has some big things planned for DDL! MRX006, dual cavity for triple therapy dry powder inhaler (DPI). Based on the open-inhale-close principle. It is suitable as an AB-rated substitutable device for triple therapy combinations.” Twitter.com, Published: [Dec. 11, 2019], site visited: [May 22, 2022], URL: <https://mobile.twitter.com/MRXdevices/status/1204684215729700864>. (Year: 2019). |